Back to Search
Start Over
Supplementary Figure 4 from Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti–PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Combinations of immunomodulatory anti-CD137 and anti-PD-1 mAbs synergize with sFlt3L and poly-ICLC against grafted B16F10 and B16-OVA melanomas.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....b0d709eebbfe80194bdd510e9dc262c1
- Full Text :
- https://doi.org/10.1158/2159-8290.22531604.v1